Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
981 participants
INTERVENTIONAL
2010-10-31
2012-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of a Male-focused Intervention to Prevent Intimate Partner Violence in a Conflict-affected Setting
NCT01803932
Preventing Intimate-partner Violence: Impact Evaluation of Engaging Men Through Accountable Practice in Eastern DRC
NCT02765139
Indashyikirwa IPV Prevention Trial in Rwanda
NCT03477877
Impact of Family-Centered Care for Intimate Partner Violence (IPV)
NCT06071299
Impact of Microfinance and Participatory Gender Training for Women in Reducing Intimate Partner Violence
NCT02592252
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
VSLA + gender dialogue groups: treatment
VSLA + Gender dialogue groups
Dialogue groups discussing household discussion making and gender norms facilitated by IRC.
VSLA only: control
VSLA + Gender dialogue groups
Dialogue groups discussing household discussion making and gender norms facilitated by IRC.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
VSLA + Gender dialogue groups
Dialogue groups discussing household discussion making and gender norms facilitated by IRC.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18+
* Source of stable income
Exclusion Criteria
* prior experience with microcredit
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Innovations for Poverty Action
OTHER
International Rescue Committee
OTHER
Yale University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
jhumka gupta, ScD
Role: PRINCIPAL_INVESTIGATOR
Yale University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
International Rescue Committee
Abidjan, , Côte d’Ivoire
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Gupta J, Falb K, Kpebo D, Annan J. Abuse from in-laws and associations with attempts to control reproductive decisions among rural women in Cote d'Ivoire: a cross-sectional study. BJOG. 2012 Aug;119(9):1058-66. doi: 10.1111/j.1471-0528.2012.03401.x. Epub 2012 Jun 7.
Blay-Tofey M, Lee BX. Preventing gender-based violence engendered by conflict: The case of Cote d'Ivoire. Soc Sci Med. 2015 Dec;146:341-7. doi: 10.1016/j.socscimed.2015.10.009. Epub 2015 Oct 14.
Gupta J, Falb KL, Lehmann H, Kpebo D, Xuan Z, Hossain M, Zimmerman C, Watts C, Annan J. Gender norms and economic empowerment intervention to reduce intimate partner violence against women in rural Cote d'Ivoire: a randomized controlled pilot study. BMC Int Health Hum Rights. 2013 Nov 1;13:46. doi: 10.1186/1472-698X-13-46.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1007007040
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.